Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

Journal of the American College of Cardiology

Volumn 31, Issue 2, 1998, Pages 391-398

  Tsutamoto, Takayoshi ^a   Hisanaga, Tomoko ^a   Wada, Atsuyuki ^a   Maeda, Keiko ^a   Ohnishi, Masato ^a   Fukai, Daisuke ^a   Mabuchi, Naoko ^a   Sawaki, Masahide ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; INTERLEUKIN 6; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT;

ADOLESCENT; ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMIC PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; FOLLOW-UP STUDIES; FORECASTING; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0031977811     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00494-4     Document Type: Article

References (38)

1. Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN. The neurohumoral axis in congestive heart failure. Ann Intern Med. 101:1984;370-377.
2. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 311:1984;819-823.
3. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation. 77:1988;721-729.
4. Remes J, Tikkanen I, Fyhrquist F, Ryoarala K. Neuroendocrine activity in untreated heart failure. Br Heart J. 65:1991;249-255.
5. Cody RJ, Hass GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with extent of pulmonary hypertension in patients with chronic heart failure. Circulation. 85:1994;504-509.
6. Tsutamoto T, Wada A, Maeda Y, Adachi T, Kinoshita M. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. J Am Coll Cardiol. 23:1994;1427-1433.
7. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS Trial Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-6.
8. Tsutamoto T, Hisanaga T, Fukai D, et al. Prognostic value of plasma intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol. 76:1995;803-808.
9. Gottlieb SS, Kukin MC, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 13:1989;1534-1539.
10. Hall C, Rouleau JL, Moye L, et al. N-terminal proatrial natriuretic factor an independent predictor of long-term prognosis after myocardial infarction . Circulation. 89:1994;1934-1942.
11. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronoc heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic sympatheic left ventricular dysfunction . Circulation. 96:1997;509-516.
12. Levine B, Kalman J, Mayer L, Howard M, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241.
13. Mann DL, Young JB. Basic mechanisms in congestive heart failure recognizing the role of proinflammatory cytokines . Chest. 105:1994;897-904.
14. Ferrai R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 92:1995;1479-1486.
15. Kishimoto T. The biology of interleukin-6. Blood. 74:1989;1-10.
16. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
17. Lefer AM, Tsao P, Aoki N, Palladino MA. Mediation of cardioprotection by transforming growth factor-β Science. 249:1990;61-64.
18. Tsujikawa T, Ebisui C, Fujita J, et al. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun. 207:1995;168-174.
19. Tsujikawa T, Fujita J, Ebisui C, et al. Interleukin-6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin-6 transgenic mice. J Clin Invest. 97:1996;244-249.
20. Wiedermann CJ, Beimpold H, Herold M, Knapp E, Braunsteiner H. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol. 22:1993;1897-1901.
21. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction a report from the Studies Of Left Ventricular Dysfunction (SOLVD) . J Am Coll Cardiol. 27:1996;1201-1206.
22. Hirano T, Yasukawa K, Harada H, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B cell lymphocytes to produce immunoglobulin. Nature. 324:1986;73-76.
23. Horii Y, Muraguchi A, Suematsu S, et al. Regulation of BSF-2/IL-6 production by human mononuclear cells macrophage-dependent synthesis of BSF-2/IL-6 by T cells . J Immunol. 141:1988;1529-1535.
24. Jirik FR, Podor TJ, Hirano T. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 production secretion by human endothelial cells. J Immunol. 142:1989;144-147.
25. Lippnow H, Libby P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest. 85:1990;731-738.
26. Xin X, Cai Y, Matsumoto K, Agui T. Endothelin-induced interleukin-6 production by rat aortic endothelial cells. Endocrinology. 136:1995;132-137.
27. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
28. Hirano H, Yoshida K, Kishimoto T, Taga T. Continuous activation of gp 130, a signal-transducing receptor component for interleukin-6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA. 92:1995;4862-4866.
29. Kubota J, Kubo S, Nishimura H, et al. Cardiorenal effects of an orally active dopamine prodrug (TA-870) in patients with congestive heart failure. J Cardiovasc Pharmacol. 14:1989;53-57.
30. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka O, Kinoshita M. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation. 87:1993;70-75.
31. Maruo N, Morita I, Shirao M, Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology. 219:1992;710-714.
32. Libert C, Brouckaert P, Shaw A, Fiers W. Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice. Eur J Immunol. 20:1990;691-694.
33. Zhang Y, Lin J-X, Vileek J. Synthesis of interleukin 6 (interferon-β2 B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem. 263:1988;6177-6182.
34. Leal-Berumen I, Snider DP, Barajas-Lopez C, Marshall JS. Cholera toxin increases IL-6 synthesis and decreases TNF-α production by rat peritoneal mast cells. J Immunol. 156:1996;316-321.
35. Ohkawa F, Ikeda U, Kanbe T, Kawasaki K, Shimada K. Effects of inflammatory cytokines on vascular tone. Cardiovasc Res. 30:1995;711-715.
36. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss mediation by interleukin-6 . Science. 257:1992;88-91.
37. Kinia DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriatr Soc. 43:1995;236-239.
38. Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 91:1995;1520-1524.